EpidStrategies participating in ASH 2020
EpidStrategies is excited to be participating in the American Society of Hematology (ASH) Annual Meeting, which will be held virtually on December 5-8, 2020. Xiaohui Jiang will… read more
Latest News
ToxStrategies scientists and colleagues publish new AOP study
ToxStrategies scientists Dr. Mark Harris, Dr. Deborah Proctor, and Dr. Chad Thompson are among the authors of a recently published study that proposes a cytotoxicity-mediated adverse outcome… read more
UK toxicologist joins ToxStrategies
ToxStrategies is pleased to announce that Dr. Kristina Ulrich has joined our Biopharmaceuticals and Pharmaceuticals practice. Dr. Ulrich is a European Registered Toxicologist (ERT) and a… read more
EpidStrategies Scientist on Leadership Panel
Dr. Naushin Hooda, an EpidStrategies Doctor of Pharmacy based in Toronto, will participate in a virtual panel discussion as part of the Canadian… read more
ToxStrategies scientist, Dr. Laurie Haws elected to Board of Directors
ToxStrategies scientist, Dr. Laurie Haws was recently elected to the Board of Directors for The Toxicology Forum. The Toxicology Forum is a leading… read more
ToxStrategies scientists publish systematic mapping and systematic reviews framework
ToxStrategies authors, Dr. Daniele Wikoff and Dr. Allison Franzen, and colleagues have published a framework for use of systematic mapping and systematic reviews in… read more
Ms. Ann Verwiel to present at ISES 30th Annual Meeting
ToxStrategies scientist, Ms. Ann Verwiel, will be presenting during the upcoming virtual 30th annual meeting of the International Society of Exposure Science. Ms…. read more
Dr. Laurie Haws to present at The Science of PFAS: Chemistry, Health and Multimedia Measurements Virtual Conference
ToxStrategies scientist, Dr. Laurie Haws, will be presenting in a virtual session at the upcoming Science of PFAS: Chemistry, Health, and Multimedia Measurements… read more